Implications Of Staphylococcal Resistance in the Critcally Ill Patient

When

Tuesday, Nov. 13, 2007

6:00 p.m. - Social Hour, Library
7:00 p.m. - Dinner, Dining Room
8:00 p.m. - Scientific Session, Williams Hall

Where

Barlow Respiratory Hospital
2000 Stadium Way
Los Angeles, CA 90026

What

Staphylococcus aureus has become resistant to many commonly used antibiotics. The emergence of antimicrobial resistance, including MRSA, makes the choice of antimicrobial therapy in critically ill patients a rapidly changing area of infectious disease medicine, and one in which physicians need to remain current, as MRSA can lead to life-threatening diseases, such as pneumonia, meningitis, endocarditis, toxic shock syndrome (TSS), and septicemia. This is of particular importance to pulmonologists and critical care physicians/intensivists responsible for the care of patients in intensive care units (ICU). This lecture will provide an update on recognition, current management, and antimicrobial therapy in staphylococcal resistance in the critically ill patient. This program is designed for physicians specializing in Pulmonary and Critical Care Medicine, Internal Medicine, Respiratory Therapists, and ICU Nurses; however, everyone is welcome.

Objectives: At the end of the presentation the participant should be able to:

• Recognize the importance of staphylococcal resistance in the critically ill patient
• Discuss the limitations of vancomycin as an anti-staphylococcal agent
• Determine the appropriate selection of antimicrobial therapy in the critically ill patient in light of the emergence of MRSA

click for registration and more info